Device Trial Radar · NCT05893420
A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning
Last checked: Nov 19, 2026Latest source record: Jul 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
30,000
Planned (sponsor's estimate)
Start
Dec 31, 2024
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- AgileMD, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Biomedical Advanced Research and Development Authority; University of Chicago; BayCare Health System; University of Wisconsin, Madison; Yale University
- First posted
- Jun 7, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In this study, the investigators will deploy a software-based clinical decision support tool (eCARTv5) into the electronic health record (EHR) workflow of multiple hospital wards. eCART's algorithm is designed to analyze real-time EHR data, such as vitals and laboratory results, to identify which patients are at increased risk for clinical deterioration. The algorithm specifically predicts imminent death or the need for intensive care unit (ICU) transfer. Within the eCART interface, clinical teams are then directed toward standardized guidance to determine next steps in care for elevated-risk patients. The investigators hypothesize that implementing such a tool will be associated with a decrease in ventilator utilization, length of stay, and mortality for high-risk hospitalized adults.
Conditions
- Sepsis
- Septicemia
- Respiratory Failure
- Hemodynamic Instability
- COVID-19
- Cardiac Arrest
- Clinical Deterioration
Interventions
eCARTv5 clinical deterioration monitoringDevice
eCART is a predictive analytic used for the identification of acute clinical deterioration built upon more than a decade of ongoing scientific research and chronicled in numerous peer-reviewed publications. eCART draws upon readily available patient data from the EHR, rapidly quantifies disease severity, and predicts the likelihood of critical illness onset.
Standard of care controlOther
Standard of care is the health system's clinical best practices and workflows for identifying high-risk patients for clinical deterioration, including other tools already built into the electronic health record (EHR). Hospitals that do not implement eCARTv5 will be compared as a control against hospitals that do implement eCARTv5.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hospital mortality for elevated risk patientsTime frame: The outcome of hospital mortality for elevated risk patients will be tracked across 12 months
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Yale New Haven Health System
New Haven, Connecticut
BayCare Health System
Clearwater, Florida
University of Wisconsin Health
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.